USPTO serial 79214379
TELIX PHARMACEUTICALS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MITTLER, ROBIN M
- Law office
- TMO LAW OFFICE 125 - SENIOR ATTORNEY
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with TELIX PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Apparatus for administering pharmaceuticals, namely, medical apparatus for introducing pharmaceutical preparations into the human body; medical apparatus for the treatment of cancer; imaging apparatus for medical use for diagnosing medical conditions; drug delivery systems, namely, applicators for pharmaceutical preparations sold without medication; all of the aforementioned for use in the detection or treatment of cancer | ACTIVE | — |
| 035 | Advertising services; business advisory services relating to product development; business consultancy; retail or wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; intermediary business services relating to the commercialisation of goods, namely, procuring of contracts for third parties for the purchase and sale of goods | ACTIVE | — |
| 042 | Scientific research; scientific research in the field of pharmacy; research on the subject of pharmaceuticals; medical research; research and development of products; providing scientific advisory services relating to immunological products; provision of scientific information in the fields of biochemistry, biotechnology and clinical trials; scientific consultancy, namely, consulting services in the fields of biotechnology, pharmaceutical research and development, and genetic science; all of the aforementioned in relation to radiopharmaceuticals and cancer | ACTIVE | — |
| 045 | licensing of intellectual property | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 30, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 26, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 11, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 15, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 15, 2021 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Oct 3, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Aug 15, 2021 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Jul 31, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 17, 2020 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 10, 2020 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 26, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 26, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 12, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 26, 2018 | MAB0 | ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE | — |
| Dec 26, 2018 | ABN0 | ABANDONMENT - INCOMPLETE RESPONSE | — |
| Dec 4, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 4, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 4, 2018 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 9, 2018 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Sep 20, 2018 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jul 27, 2018 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 26, 2018 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 6, 2018 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 5, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 28, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 27, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 27, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 22, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 1, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 1, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 30, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 29, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 28, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 22, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 18, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 17, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |